Home › Biblio

Biblio

Found 22 results

2011
DeZern AE, Sung A, Kim S, Smith DB, Karp JE, Gore SD, Jones RJ, Fuchs E, Luznik L, McDevitt M et al..  2011.  Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(9):1404-9. Abstract
Bolaños-Meade J, Smith DB, Gore SD, McDevitt MA, Luznik L, Fuchs EJ, Jones RJ.  2011.  5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(5):754-8. Abstract
Gerber JM, Qin L, Kowalski J, Smith DB, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W et al..  2011.  Characterization of chronic myeloid leukemia stem cells.. American journal of hematology. 86(1):31-7. Abstract
Smith DB, Jones RJ, Cho E, Kowalski J, Karp JE, Gore SD, Vala M, Meade B, Baker SD, Zhao M et al..  2011.  Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.. Leukemia research. 35(1):87-94. Abstract
2010
Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith DB, Matsui WH, Goodman SN, Ambinder RF et al..  2010.  High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.. Blood. 115(11):2136-41. Abstract
Karp JE, Blackford A, Smith DB, Alino K, Seung AH, Bolaños-Meade J, Greer JM, Carraway HE, Gore SD, Jones RJ et al..  2010.  Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.. Leukemia research. 34(7):877-82. Abstract
Smith DB, Kasamon YL, Kowalski J, Gocke C, Murphy K, Miller CB, Garrett-Mayer E, Tsai H-L, Qin L, Chia C et al..  2010.  K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(1):338-47. Abstract
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith DB, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD et al..  2010.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.. Blood. 115(16):3224-30. Abstract
2008
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA et al..  2008.  Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.. Leukemia research. 32(9):1439-47. Abstract
Matsui W, Wang Q, Barber JP, Brennan S, Smith DB, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C et al..  2008.  Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.. Cancer research. 68(1):190-7. Abstract
2007
Karp JE, Smith DB, Levis MJ, Gore SD, Greer J, Hattenburg C, Briel J, Jones RJ, Wright JJ, Colevas DA.  2007.  Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research. 13(15 Pt 1):4467-73. Abstract
2006
Huff CA, Matsui WH, Smith DB, Jones RJ.  2006.  Strategies to eliminate cancer stem cells: clinical implications.. European journal of cancer (Oxford, England : 1990). 42(9):1293-7. Abstract
Huff CA, Matsui W, Smith DB, Jones RJ.  2006.  The paradox of response and survival in cancer therapeutics.. Blood. 107(2):431-4. Abstract
Huff CA, Fuchs EJ, Smith DB, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH et al..  2006.  Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 12(4):414-21. Abstract
2005
Matsui W, Smith DB, Vala M, Beal N, Huff CA, Diehl LF, Jones RJ.  2005.  Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.. British journal of haematology. 128(6):853-62. Abstract
Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith DB, Flinn IW.  2005.  High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(2):93-100. Abstract
Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith DB, Jones RJ.  2005.  Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.. British journal of haematology. 130(3):373-81. Abstract
2004
Angstreich GR, Smith DB, Jones RJ.  2004.  Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.. Current opinion in oncology. 16(2):95-9. Abstract
Jones RJ, Matsui WH, Smith DB.  2004.  Cancer stem cells: are we missing the target? Journal of the National Cancer Institute. 96(8):583-5.
2003
Matsui W, Huff CA, Vala M, Barber J, Smith DB, Jones RJ.  2003.  Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation.. British journal of haematology. 121(2):251-8. Abstract
2002
Smith DB, Jones RJ, Lee SM, Piantadosi S, Vala MS, Fuller D, Gore SD, Noga SJ, O'Donnell PV, Braine H et al..  2002.  Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.. British journal of haematology. 117(4):907-13. Abstract
Matsui WH, Gladstone DE, Vala MS, Barber JP, Brodsky RA, Smith DB, Jones RJ.  2002.  The role of growth factors in the activity of pharmacological differentiation agents.. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 13(6):275-83. Abstract

Your Support is the Key

Submitted by admin on May 9, 2011 - 11:20am

Matthew Slattery

Help children like Matthew unlock their potential by becoming a Partner in Potential.

Donate Learn More